These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10719216)

  • 1. mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity.
    Chaturvedi K; Shahrestanifar M; Howells RD
    Brain Res Mol Brain Res; 2000 Mar; 76(1):64-72. PubMed ID: 10719216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
    Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding.
    Bot G; Blake AD; Li S; Reisine T
    J Neurochem; 1998 Jan; 70(1):358-65. PubMed ID: 9422382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias.
    Hothersall JD; Torella R; Humphreys S; Hooley M; Brown A; McMurray G; Nickolls SA
    Neuropharmacology; 2017 May; 118():46-58. PubMed ID: 28283391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
    Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R
    ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
    Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
    Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key residues defining the mu-opioid receptor binding pocket: a site-directed mutagenesis study.
    Mansour A; Taylor LP; Fine JL; Thompson RC; Hoversten MT; Mosberg HI; Watson SJ; Akil H
    J Neurochem; 1997 Jan; 68(1):344-53. PubMed ID: 8978745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
    Connor M; Schuller A; Pintar JE; Christie MJ
    Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
    Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
    ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of μ-opioid receptor activation by acidic pH is dependent on ligand structure and an ionizable amino acid residue.
    Meyer J; Del Vecchio G; Seitz V; Massaly N; Stein C
    Br J Pharmacol; 2019 Dec; 176(23):4510-4520. PubMed ID: 31355457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
    Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
    Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
    McLaughlin JP; Chavkin C
    Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.
    Wang HL
    J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
    Chaipatikul V; Loh HH; Law PY
    J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.